Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis
Authors:
- 1 March 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 56 (5) , 668-674
Abstract
Cripto is a 188 amino‐acid protein containing a central segment that shares amino‐acid sequence homology with epidermal growth factor (EGF) and transforming growth factor alpha (TGF‐α). The EGF receptor, EGF and TGF‐α are expressed in the normal human pancreas, and are over‐expressed in human pancreatic cancer. Therefore, in the present study we sought to determine whether cripto is found in the normal human pancreas and whether its expression is altered in pancreatic cancer. Because chronic pancreatitis (CP) is associated with interstitial fibrosis similar to that observed in pancreatic cancer, we also examined cripto expression in pancreatic tissues from patients with CP. In the normal pancreas, cripto immunoreactivity was found at moderate levels in most ductal cells and was present very faintly in a rare acinar cell. In 26 of 58 pancreatic cancers, cripto immunoreactivity was present in many cancer cells. Its presence was associated with advanced tumor stage, but not with shorter post‐operative survival. Cripto was also present in acinar and ductal cells adjacent to the cancer cells, and in many ductal and atrophic acinar cells in the CP samples. Northern blot analysis revealed a marked increase in cripto mRNA levels in the cancer and CP samples. By densitometry, there was a 11 ‐ and 4‐fold increase in cripto mRNA levels in pancreatic cancer and CP respectively. Southern blot analysis did not reveal an increase in gene copies encoding cripto either in cancer or in CP. These findings indicate that cripto expression may contribute to disease progression in pancreatic cancer, and implicate cripto in the histopathological alterations that occur in the pancreas both in cancer and in CP.Keywords
This publication has 18 references indexed in Scilit:
- Pancreatitis and the Risk of Pancreatic CancerNew England Journal of Medicine, 1993
- p53 Mutations are common in pancreatic cancer and are absent in chronic pancreatitisCancer Letters, 1993
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992
- Treatment of Duct Carcinoma of the Pancreas with the LH-RH Analogue BuserelinPancreas, 1992
- Growth factor signaling by receptor tyrosine kinasesNeuron, 1992
- Differential expression of epidermal growth factor-related proteins in human colorectal tumors.Proceedings of the National Academy of Sciences, 1991
- Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal CarcinomasJapanese Journal of Cancer Research, 1991
- High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomasInternational Journal of Cancer, 1989
- Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.Proceedings of the National Academy of Sciences, 1987
- Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer.Proceedings of the National Academy of Sciences, 1986